Neuralink, an American neurotechnology developer, is now enrolling participants for a human clinical trial of its Precise Robotically Implanted Brain Computer Interface (PRIME). In a September news announcement, the company said its R1 surgical robot would place Neuralink’s N1 implant into trial participants with the goal of “enabling people with paralysis to control external devices…